Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Salutsantjoan     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


My photo
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com




Tuesday, June 11, 2013

Manejo de anticoagulación: cirugía y procedimientos invasivos

(Review, NEJM) - PulmCCM June 07, 2013

"NOTE: This is a summary of an article in a medical journal, provided as a service to physicians. It is not medical advice. No one should never make changes to their anticoagulation treatment except under a physician’s supervision. Please read the Terms of Use before proceeding.
One in 50 people in the U.S. are taking long-term anticoagulation therapy for a condition like atrial fibrillation, a mechanical heart valve, or a clotting disorder resulting in DVT / PE. Millions more with coronary artery disease or strokes are taking antiplatelets drug like Plavix, and often aspirin as well. About 1 in 10 people on anticoagulation therapy undergo surgery or an invasive procedure each year, and the management of their anticoagulation medicines can be challenging: the physician is expected to simultaneously prevent serious bleeding during the surgery, and also clotting resulting in pulmonary embolism, heart attack, or embolic stroke. Tricky!"

También te podría interesar:
  1. Corrección de anticoagulación excesiva
  2. Dabigatran (Pradaxa®)
  3. Manejo de la anticoagulación
  4. Rivaroxaban (Xarelto)
  5. Trauma craneal en pacientes anticoagulados